Onchocerciasis
Case-control study Mahenge, Tanzania.
Year Started: 2021
HLA typing among cases and controls of onchocerciasis-associated epilepsy cases.
- Access:
- Open to applicants
- Type:
- Case-control
- Status:
- Completed
- Consent restrictions:
-
No restrictions
| Associated Data Type |
Procurement Timeframe |
| Biomarker datasets |
0 - 3 months |
| Clinical records |
0 - 3 months |
| Genomic datasets |
0 - 3 months |
| Survey data |
0 - 3 months |
| Participant Ethnicity |
0 - 3 months |
| Microbiological results |
0 - 3 months |
Both sexes
Child (6 - 12 years)
101 - 500 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Microscopic Assessment |
% of Sample Set |
| Serum |
|
-85°C to -60°C |
|
Not applicable |
75% -99% |
| Dried whole blood |
|
-85°C to -60°C |
|
Not applicable |
75% -99% |
Both sexes
Adolescent (12 - 18 years)
101 - 500 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Microscopic Assessment |
% of Sample Set |
| Serum |
|
-85°C to -60°C |
|
Not applicable |
75% -99% |
| Dried whole blood |
|
-85°C to -60°C |
|
Not applicable |
75% -99% |
Both sexes
Young adult (18 - 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Microscopic Assessment |
% of Sample Set |
| Serum |
|
-85°C to -60°C |
|
Not applicable |
100% |
| Dried whole blood |
|
-85°C to -60°C |
|
Not applicable |
100% |